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MaTranscatheter aortic valve replacement (TAVR) using a balloon-expandable valve is an accepted alternative to surgical
replacement for severe, symptomatic aortic stenosis in high risk or inoperable patients. Intraprocedural transesophageal
echocardiography (TEE) offers real-time imaging guidance throughout the procedure and allows for rapid and accurate
assessment of complications and procedural results. The value of intraprocedural TEE for TAVR will likely increase in the
future as this procedure is performed in lower surgical risk patients, who also have lower risk for general anesthesia, but a
greater expectation of optimal results with lower morbidity and mortality. This imaging compendium from the PARTNER
(Placement of Aortic Transcatheter Valves) trials is intended to be a comprehensive compilation of intraprocedural
complications imaged by intraprocedural TEE and diagnostic tools to anticipate and/or prevent their occurrence.
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high-risk or inoperable patients (1,2). Although echo-
cardiography is important in the pre-procedural eval-
uation of patients undergoing TAVR (particularly to
characterize and quantitate the severity of aortic ste-
nosis [3,4] and assist in valve sizing [5,6]), other im-
aging modalities (e.g., computed tomography) are
also useful for assessing the aortic valvular complex
before transcatheter heart valve (THV) implantation
(7–18). However, intraprocedural transesophageal
echocardiography (TEE) offers the signiﬁcant advan-
tage of accurate real-time imaging and is incompa-
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AB BR EV I A T I O N S
AND ACRONYM S
AV = aortic valve
CMR = cardiac magnetic
resonance
LCA = left coronary artery
LV = left ventricular
PAR = paravalvular aortic
regurgitation
TAVR = transcatheter aortic
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289risk patients who are subjected to TAVR. Sites using
the “minimalist approach” are highly experienced,
and recommending this approach to implant opera-
tors with lower procedural volumes may be ill
advised. In fact, in a study of an intermediate risk
population using the minimalist approach (26) the
30 day mortality rate is in fact higher than that re-
ported in a higher risk patient population of the
PARTNER (Placement of Aortic Transcatheter Valves)
trial (30).SEE PAGE 337
valve replacement
TEE = transesophageal
echocardiography
THV = transcatheter heartBecause TAVR is a relatively new procedure, it is
important for both experienced and novice operators
to be aware of the echocardiographic appearance of
major complications and for the interventionalists
to react to those ﬁndings. There have been multi-
ple reports of complications of the procedure,
including access issues (31–33), aortic root trauma
(34–36), malpositioning of the THV (37–39), coronary
obstruction (40,41), paravalvular regurgitation (PAR)
(42–49), ventricular septal or mitral leaﬂet perfora-
tion (35), and cardiogenic shock (50,51). This imaging
compendium from the PARTNER trials is intended to
be a comprehensive compilation of intraprocedural
complications imaged by using intraprocedural TEE
and diagnostic tools to anticipate and/or prevent
their occurrence. The compendium uses both stan-
dard and structure-speciﬁc imaging planes outlined
in the recent American Society of Echocardiography
(ASE) guidelines (25) as well as the guidelines
for 3-dimensional (3D) echocardiographic imaging
acquisition and display (52). Imaging planes and
transducer angles are well described in the guidelines
and will not be included in this paper.
The intended audience for this report includes
experienced and beginning “procedural” echocardi-
ographers, as well as interventionalists and surgeons
performing TAVR. It is intended to serve both as
a teaching guide providing “tips and tricks” to assist
in daily practice and as a reference work con-
taining unusual or exceptional ﬁndings. Because the
PARTNER trials represent the initial experience with
TAVR in the United States, many of the ﬁndings
indicate steps on the learning curve for the ﬁeld as
well as for each of the participating research sites,
almost none of whom had experience with this pro-
cedure. Documenting these early missteps is highly
informative even though some of these ﬁndings may
rarely occur for current, more experienced teams.
A total of 527 patients in the PARTNER 1
trial underwent TAVR with the ﬁrst generation
balloon-expandable THV (Edwards SAPIEN, EdwardsLifesciences, Irvine, California). The list of
complications in Table 1 was compiled by
reviewing the adverse event log from the
PARTNER I trial and the core laboratory re-
cords for complications noted on transthoracic
echocardiographic follow-up. Complications
that could be imaged by intraprocedural
echocardiography were determined and sites
polled for the availability of the original TEE
images. Images were collected and reviewed.
Of note, all the complications on the list had
associated images, which are presented here.
Important imaging considerations are sum-
marized in Table 2.COMPLICATIONS
STIFF WIRE LOCATION. Complications can occur
during extra-stiff wire positioning. The most common
complication is entanglement in the mitral apparatus.
This is frequently recognized by paying strict atten-
tion to any change in mitral valve morphology or
severity of regurgitation (Figure 1A, Online Video 1).
3D imaging may help conﬁrm the site of entangle-
ment (Figure 1B). When recognized, repositioning the
wire may avoid other complications, such as rupture
of mitral chordal attachments with subsequent ﬂail
leaﬂet (Figures 1C and 1D). The wire may also perforate
the septum during transapical procedures, causing a
ventricular septal defect.
Balloon aortic valvuloplasty complications. For the
balloon-expandable valve, most operators use a
balloon aortic valvuloplasty (BAV) to increase valve
opening and improve precise positioning of the THV.
Some investigators use the stability of the balloon
catheter during BAV as a possible predictor of
operator-independent motion of the THV and sub-
sequent malpositioning. BAV is also used as
adjunctive imaging for THV sizing (53–55) and to
predict the ﬁnal position of the native cusps after
TAVR. Although complications with BAV are rare,
they vary in appearance and many can be imaged
during the procedure (e.g., severe aortic regurgita-
tion, pericardial effusion) by using intraprocedural
TEE (56).
Immediately after BAV, it is important to assure
the interventionalists that the valve remains intact
and that the aortic regurgitation is not signiﬁcantly
increased. In the ﬁrst case (Figures 2A and 2B, Online
Video 2), the etiology of the regurgitation is an
avulsed aortic valve (AV). In the second case
(Figures 2C and 2D, Online Video 3), the etiology is a
displaced and ﬁxed left coronary cusp. The latter
complication may resolve spontaneously if the cusps
valve
TABLE 1 Intraprocedural Complications Reported in the PARTNER Database (N ¼ 527)
Failure to implant:
a. Secondary to superior motion of balloon during
BAV in setting of large sigmoid septum
1 (0.2%)
Balloon aortic valvuloplasty complications
a. Severe aortic regurgitation: stuck or avulsed valve
b. Aortic trauma
3 (0.6%)
Acute hemodynamic compromise
a. LV collapse (expired)
b. RV standstill (expired)
Left ventricle ¼ 5 (1%)
Right ventricle ¼ 1 (0.2%)
Malposition
a. Requiring surgical bailout (too low) or
valve-in-valve procedure
b. Embolization:
i. Into aorta: due to loss of pacing capture (n ¼ 1)
ii. Into left ventricle (n ¼ 1)
Surgical bail-out ¼ 2 (0.4%)
Valve-in-valve ¼ 2 (0.4%)
Aortic complications
a. Aortic dissection (proximal) caused by
embolization of ﬁrst valve
b. Aortic annular rupture
c. Descending aortic rupture
d. Periaortic hematoma
i. With RCA compression
ii. With no hemodynamic consequence
Dissection ¼ 2 (0.4%)
Annular rupture ¼ 3 (0.6%)
Periaortic hematoma ¼ 3 (0.6%)
Descending aorta rupture ¼ 1 (0.2%)
Signiﬁcant aortic regurgitation
a. Severe central AR
i. Post-BAV
ii. Post-THV (malposition, stuck cusp)
b. Severe paravalvular AR
i. Treated with post-dilation
ii. Treated with valve-in-valve procedure (n ¼ 5)
Severe central AR in THV ¼ 2 (0.4%)
BAV complication ¼ 3 (0.6%)
Valve-in-valve procedure ¼ 5 (1%)
Bleeding/pericardial effusion
a. Post transapical TAVR
i. At cannulation site
ii. Adjacent to cannulation site
iii. Hemorrhagic pleural effusion
(requiring pleurodesis)
b. Pacemaker perforation
c. LV or RV tear
d. Post-BAV after chest compressions
Apical bleeding ¼ 2 (0.4%)
RV cannulated ¼ 1 (0.2%)
Pacemaker ¼ 2 (0.4%)
LV perforation ¼ 3 (0.6%)
BAV CPR ¼ 1 (0.2%)
Fistulas
a. Aorta-to-right atrium ﬁstula
b. Membranous VSD
3 (0.6%)
Coronary occlusion
a. RCA (due to periaortic hematoma)
b. Left main occlusion
c. Post-transapical cannulation (distal LAD)
3 (0.6%)
Mitral valve regurgitation (acute)
a. Mitral valve cusp perforation
b. Wire entanglement
1 (0.2%)
Total 49 (9.3%)
Values are n (%).
AR¼ aortic regurgitation; BAV¼ balloon aortic valvuloplasty; CPR¼ cardiopulmonary resuscitation; LAD ¼ left
anterior descending coronary artery; LV ¼ left ventricular; PARTNER ¼ Placement of Aortic Transcatheter Valves;
RCA ¼ right coronary artery; RV ¼ right ventricular; TAVR ¼ transcatheter aortic valve replacement; THV ¼
transcatheter heart valve; VSD ¼ ventricular septal defect.
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290quickly resume their “closed” position; however,
because of the acute hemodynamic compromise that
frequently occurs with torrential acute aortic regur-
gitation, immediate deployment of the THV is usually
indicated.
BAV can also be used as a diagnostic test to antic-
ipate possible complications. Rupture of the balloon
during BAV is typically caused by spicules of calcium.
If rupture of the balloon occurs during deploy-
ment of the THV, the valve may be signiﬁcantlyunderdeployed, which increases the risk of acute THV
embolization. Continuous imaging during BAV may
also predict the ﬁnal location of the bulky calciﬁed
cusps in relation to the aortic root wall as well as the
left main coronary artery. In the setting of small si-
nuses of Valsalva, bulky calciﬁed cusps may threaten
the integrity of the aortic root, and deformation of the
root can be imaged during BAV (Figure 3A, Online
Video 4) and help predict subsequent trauma to the
aorta with TAVR, such as a periaortic hematoma
(Figure 3B, Online Video 5). Coronary occlusion has
been associated with female sex, small aortic root
(sinus diameter 27.8  2.0 mm), and height of the left
main coronary above the annulus. Because no ob-
structions appear to be related to THV strut obstruc-
tion, the likely mechanism is direct obstruction by the
calciﬁed left coronary cusp (41). Intraprocedural
measurement of the left main coronary height (above
the annulus) and length of the left coronary cusp
using 3D echocardiography (Figures 4A and 4B) alerts
the interventionalists to the possibility of left main
coronary artery occlusion by a bulky, calciﬁed left
coronary cusp. Once a discordance between coronary
height and cusp length is detected (with cusp length
typically >2 mm longer than the coronary height), the
diameter of the relevant sinus of Valsalva is then
measured. If this diameter is #30 mm, the risk for
occlusion is signiﬁcant, and intraprocedural imaging
during BAV can then be used as a diagnostic test
allowing direct visualization of the oriﬁce of the left
main coronary artery with maximum balloon inﬂation
(Figure 5, Online Video 6). In the example shown,
bulky calcium ﬁlled the left main ostium, and a
crimped coronary stent was adjunctively positioned
in the left main coronary artery before TAVR. After
valve deployment, there was nearly complete occlu-
sion of the left main, and the coronary stent was
quickly deployed.
Acute hemodynamic compromise. In the setting of
hemodynamic collapse, the prompt and accurate
diagnosis of the underlying problem has paramount
importance. While the anesthesiologist is managing
the hemodynamics and the ventilator, the etiology
of the acute hypotension must be rapidly diagnosed
by using intraprocedural TEE (25). Rapid assess-
ment of valvular (mitral, THV, tricuspid, and pul-
monic) morphology/function, aortic pathology,
coronary patency, biventricular function, root
rupture, and pericardial effusion can be performed
within minutes. Hypovolemia and bleeding can
be suggested by comparing ventricular size
with baseline imaging. Ruling out such causes is
invaluable for the treatment of these potentially
lethal complications.
TABLE 2 Summary of Echocardiographic Imaging Recommendations
Complication Imaging Recommendations
Wire position Entanglement in mitral apparatus
or ventricular perforation
1. 2DE and particularly 3DE imaging of wire position
2. Imaging of mitral valve: change in severity of mitral regurgitation or chordal
disruption
3. Exclude new pericardial effusion or shunt
BAV Coronary occlusion
Severe aortic regurgitation
Aortic trauma
1. Image during and immediately after BAV for aortic leaﬂet motion and aortic
regurgitation
2. Image the coronary arteries (particularly the left main) for obstruction by the calci-
ﬁed leaﬂets
3. Image the location of the displaced calciﬁed leaﬂets for possible deformation of the
aortic wall or annulus
Pacing or at any time
during procedure
Acute hemodynamic collapse 1. Exclude acute valvular regurgitation
2. Exclude aortic root trauma
3. Exclude acute ventricular dysfunction
4. Exclude coronary obstruction
5. Exclude pericardial effusion/tamponade
Positioning of transcatheter valve Malpositioning 1. Three different positions should be imaged typically from the mid-esophageal long
axis view: during native beats, during pacing, and after ﬁnal deployment
2. During nonpaced beats, the diastolic valve position is w50% above and below the
annulus. In the setting of normal ventricular function, the valve is typically higher in
systole and should approximate the paced beat position
3. During paced beats the valve should be 30% to 40% (w5 to 6 mm) below the
annulus
4. Optimal ﬁnal position is 10% to 20% (or 2 to 3 mm) below the annulus
5. Superior or aortic edge of the stented valve should be imaged; the native calciﬁed
cusps must be covered by 1 to 2 mm while remaining inferior to the sinotubular
junction
Transapical cannulation Cannulation site misplacement 1. Conﬁrm location of the transapical puncture site by imaging the apex (either from
mid-esophageal views or transgastric views)
2. The site should avoid the right ventricle and be angulated away from the interven-
tricular septum
3. Assess post-TAVR apical wall motion and exclude persistent transapical ﬂow
Deployment Aortic dissection or periaortic
hematoma
1. Estimate risk of aortic trauma with evaluation of calcium within the left ventricular
outﬂow tract, sinuses, and sinotubular junction
2. Watch location of displaced calcium during BAV and during valve deployment
Paravalvular aortic regurgitation 1. Appropriately size the THV with 3DE measurement of the annulus
2. Estimate risk of paravalvular regurgitation with evaluation of calcium within the
LVOT and annulus
3. Assess likelihood for effective post-dilation (less effective with severe LVOT calcium)
4. Assess risk of post-dilation (i.e., left main occlusion or annular/aortic rupture)
Coronary occlusion 1. Estimate risk of coronary occlusion with 3DE measurement of left coronary artery
height and left coronary cusp length
2. Estimate risk of coronary occlusion by observing the left main oriﬁce and displace-
ment of calcium during BAV
Acute LVOT obstruction 1. Assess risk (i.e., small, hypertrophied LV, narrow LVOT, septal hypertrophy)
2DE ¼ 2-dimensional echocardiography; 3DE ¼ 3-dimensional echocardiography; LVOT ¼ left ventricular outﬂow tract; other abbreviations as in Table 1.
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291Rapid pacing is used to reduce forward ﬂow during
both BAV and TAVR. In those patients (typically with
signiﬁcantly reduced baseline left or right ventricular
function), the 5 to 10 s of low forward ﬂow may cause
signiﬁcant global or regional ischemia, resulting in
severe persistent hypotension or even cardiac arrest/
pulseless electrical activity (Figure 6). Allowing these
patients to recover their blood pressure and ventric-
ular function between BAV and TAVR may avoid
signiﬁcant hemodynamic compromise.
Malposition and failure to implant. Marked and typi-
cally focal hypertrophy of the basal septum is not un-
common in elderly subjectswith severe aortic stenosis.
In the setting of marked hypertrophy as well as dy-
namic narrowing of the left ventricular outﬂow tract
(LVOT), there are a number of risks, primarily relatedto accurate placement of the balloon-expandable
valve. This dynamic narrowing can be best appreci-
ated by using 3D TEE (Figure 7, Online Video 7).
Operator-independent motion of the valve prosthesis
(either ventricular or aortic) due to marked dynamic
narrowing of the LVOT can result in signiﬁcant
malposition of the valve (Figure 8, Online Video 8).
There are no strict criteria for septal thickness or de-
gree of LVOT narrowing that would warrant aborting
the procedure; however, the BAVmay again be helpful
in the decision-making process. One patient in the
current study had severe septal hypertrophy that
pushed the BAV balloon into the ascending aorta on
repeated valvuloplasties; this increased the concern of
malpositioning, which prompted the interventionalist
to abort the procedure.
FIGURE 1 Acute Severe Mitral Regurgitation
During stiff wire positioning, malcoaptation of the mitral valve leaﬂet (A, red arrow) (Online Video 1), resulting in severe mitral regurgitation,
may be the ﬁrst clue to entanglement of the wire in the mitral apparatus (B, dashed red arrow). With repositioning of the wire, coaptation
of the mitral valve is now normal (C, blue arrow) with mild mitral regurgitation. The correct position of the wire is conﬁrmed by using
3-dimensional imaging (D, dashed yellow arrow).
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292A large meta-analysis of 9,251 patients from
46 studies reported a low rate of bailout surgery
(1.1  1.1%); the most frequently reported reason for
emergent surgery was embolization/dislocation of
the AV prosthesis (41%) (57). Malpositioning of the
valve is also recognized as an important factor
contributing to the presence of paravalvular aortic
regurgitation (PAR) as well as poor THV hemody-
namics, mitral valve compromise, and conduction
defects (35,58–66).
Accurate positioning of the balloon-expandable
valve requires an understanding of the motion and
shortening of the THV during deployment. Fluoros-
copy has shown that the device-center upper move-
ment during ﬁnal deployment was (on average) 2.0 
1.43 mm (range –1.3 to 4.6 mm), with shortening of
the device due to asymmetrical upward movement of
the ventricular edge of THV by 3.2  1.4 mm and the
upper (aortic) edge by only 0.75  1.50 mm (67). The
optimal ﬁnal THV deployment position resulted in
17% of the THV below the base of the aortic sinuses
(determined by pigtail catheter position or aorto-
graphy); this translated to 33% of the valve below the
sinuses during the ﬁnal pacing run. Multivariateanalysis revealed that greater upward movement
was seen with moderate and severe (vs. mild)
AV calciﬁcation and smaller aortic sinus volume.
Valve design iteration (ﬁrst generation balloon-
expandable or second generation balloon-expandable
valve), procedural access (transfemoral vs. trans-
apical), and interventricular septum width did not
affect THV movement. Similar motion and shortening
can be seen with echocardiography; however, the
valve is positioned not by the lowest border of
the sinus of Valsalva but rather by the hinge-point of
the aortic cusps (i.e., the virtual annulus), which may
be slightly “aortic” to the ﬂuoroscopic landmark
(Figure 9A). Because the valve typically moves up
(aortic) during the pacing run, mimicking the “sys-
tolic” position during nonpaced beats, this nonpaced,
diastolic valve position should be w50% below the
hinge-point of the aortic cusps (Figure 9B). Because
the ideal position of the valve is 2 to 3 mm below the
annulus and the shortening of the second generation
balloon-expandable valve is 3 mm primarily from
the ventricular side, the valve should be typically
30% to 40% (w5 to 6 mm) below the echocar-
diographic annulus during the ﬁnal pacing run
FIGURE 3 Aortic Trauma Predicted by BAV
Bulky calciﬁed cusps cause deformation of the root during BAV (A, yellow arrow) (Online Video 4). This patient suffered a periaortic hematoma
within minutes of transcatheter valve deployment (B, red arrow) (Online Video 5). Abbreviation as in Figure 2.
FIGURE 2 Complications of BAV
Long axis views immediately after balloon aortic valvuloplasty (BAV) show an avulsed leaﬂet seen in systole (A, blue arrow) (Online Video 2),
resulting in severe aortic regurgitation in diastole (B, yellow arrow). Short axis views immediately after BAV show immobile aortic cusps in an
“open” position (C, red arrows) (Online Video 3), resulting in severe aortic regurgitation in diastole (D, yellow arrow).
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FIGURE 4 Intraprocedural Measurement of the LM Coronary Height (Above the Annulus) and Length of the LCC by
Using 3D Echocardiography
(A) Shows multiplanar reconstruction of the 3-dimensional (3D) volume into the transverse, sagittal, and coronal planes. Typically, the coronal
plane must be used to simultaneously image the annulus-to-left main (LM) height (B). LCC ¼ left coronary cusp.
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294(Figure 9C, Online Video 9). The ﬁnal position of the
optimally deployed valve is w10% to 20% (w2 to 3
mm) below the hinge-points of the aortic cusps
(Figure 9D). In addition to positioning according to
the ventricular edge of the crimped THV, assessing
the superior or aortic edge of the stented valve should
be performed; the native calciﬁed cusps must be
covered by 1 to 2 mm (given thew1 mm shortening of
the valve from this end and despite the minimal su-
perior [aortic] motion of the THV), while remaining
inferior to the sinotubular junction.
With transapical or transaortic deployment, the
operator can reposition the valve during this ﬁnal
critical stage in a controlled, predictable way (Figure
10A). However, for transfemoral deployment, precise
controlled movements remain more difﬁcult, which
can risk malpositioning. Loss of pacing capture dur-
ing ﬁnal deployment may also result in signiﬁcant
superior motion of the valve into the aorta in the
setting of active ventricular contraction (Figure 10B).
Positioning too low in the ventricle (Figure 10C) risks
leaving leaﬂets uncovered or creating leaﬂet over-
hang, leading to signiﬁcant central aortic regurgita-
tion. Although a small amount of native leaﬂet
overhang is not uncommon (particularly near the
commissures where the leaﬂet attaches to the sino-
tubular junction), leaving a signiﬁcant amount of
calciﬁed, rigid leaﬂet above the THV (Figure 11A,
Online Video 10) may lead to complications. Becausethe calciﬁed leaﬂets are the primary means of
anchoring the THV, if the THV has been implanted
too low with signiﬁcant leaﬂet overhang, there can be
acute (68,69) or delayed (70–72) migration of the
valve into the ventricle. In theory, the calciﬁed
overhanging leaﬂets may exert continued downward
force on the THV, thus contributing to the proximal
migration. Leaﬂet overhang can also contribute to
valve dysfunction or early valve degeneration. The
use of the intraprocedural TEE is instrumental in the
diagnosis of native aortic overhang. The example
shown (Figure 11B, Online Video 11) reﬂects acute THV
leaﬂet entrapment, resulting in signiﬁcant aortic
regurgitation.
Aortic complications. A number of aortic complications
can occur as a result of the TAVR procedure,
including aortic dissections, thoracic aorta perfora-
tion with resulting hemorrhage, and aortic annular
rupture.
Aortic Dissection. Proximal aortic dissection may occur
immediately (intraprocedural) or become evident
later. The postulated etiology is trauma from the
procedure itself (i.e., balloon dilation, the intro-
ducing catheter, deployment of the THV) or from
displacement of sharp, bulky calcium during the
procedure. Some dissections may be treated conser-
vatively; however, if an acute dissection extends
proximal into the sinuses of Valsalva, surgical inter-
vention may then be necessary (particularly if the
FIGURE 5 LM Coronary Artery Occlusion Predicted by BAV
Simultaneous multiplane imaging shows the patent LM coronary artery (A, yellow arrow) (Online Video 6). With balloon inﬂation during BAV
(B) the bulky calcium of the LCC occludes the ostium (red arrow). This patient required a LM stent immediately after transcatheter aortic valve
replacement (TAVR). Abbreviations as in Figures 2 and 4.
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295coronary arteries are threatened). An acute, intra-
procedural proximal dissection is shown in Figure 12
(Online Video 12). This complication can lead to acute
tamponade necessitating open repair but often with a
poor outcome. Some dissections may be undiagnosed
at the time of implantation, suggesting a more benign
complication. Figure 13 (Online Video 13) is an
example of a proximal aortic dissection diagnosed
late (>6 months) after TAVR. The dissection ﬂap
extended to the sinotubular junction but not into the
sinuses, and the patient was treated conservatively.
Aortic Annular Rupture. A recent multicenter retro-
spective study (73) studied 31 patients with aortic
root rupture (20 with annular rupture and 11 with
periaortic hematoma) and compared them with
31 matched control subjects. Patients with aortic rootrupture had a higher degree of subannular/LVOT
calciﬁcation quantiﬁed by an Agatston score of
181.2  211.0 versus 22.5  37.6 (p < 0.001), a higher
frequency of $20% annular area oversizing (79.4% vs.
29.0%; p < 0.001), and an increased need for balloon
post-dilation (22.6% vs. 0.0%; p ¼ 0.005). In condi-
tional logistic regression analysis for the matched
data, moderate/severe LVOT/subannular calciﬁ-
cations (odds ratio: 10.92 [95% conﬁdence inter-
val: 3.23 to 36.91]; p < 0.001) and prosthesis
oversizing $20% (odds ratio: 8.38 [95% conﬁdence
interval: 2.67 to 26.33]; p < 0.001) were associated
with aortic root contained/noncontained rupture.
TEE imaging can be a valuable tool for evaluating
the extent and location of LVOT calcium. This in-
formation is important in estimating the risk for
FIGURE 6 Acute Hemodynamic Collapse
Baseline ventricular function was normal in simultaneous multiplane imaging (A); however, after a prolonged pacing run during valve deployment,
there was severe signiﬁcant ventricular dysfunction (B) with resulting dense spontaneous contrast (slow ﬂow) secondary to low cardiac output.
FIGURE 7 Septal Hypertrophy and Dynamic Narrowing of the LVOT
In this dual-plane 3-dimensional image of the aortic valve, dynamic narrowing of the left ventricular outﬂow tract (LVOT) can be seen
(yellow arrows) (Online Video 7).
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FIGURE 8 Operator-Independent Motion of the THV Due to Dynamic Narrowing of the LVOT
In (A), the position of the transcatheter heart valve (THV) can be seen (red insert and cartoon). With balloon inﬂation during deployment (B),
there is prominent superior motion of the THV (green insert and cartoon), which results in positioning of the THV above the annulus (yellow
arrow) (Online Video 8). Abbreviation as in Figure 7.
FIGURE 9 Positioning of the THV
(A) (modiﬁed from Dvir et al. [67]) shows the desired ﬂuoroscopic position of the valve just before balloon inﬂation (during rapid pacing).
(B) shows the transesophageal echocardiographic position during native rhythm and in diastole, which results in a superior positioning
during pacing (C). Shortening of the valve results in positioning of the proximal edge of the THV 1 to 2 mm below the native annulus (D)
(Online Video 9). Abbreviation as in Figure 8.
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FIGURE 10 Malpositioning of the Valve
(A) shows a well-positioning valve with typically 20% of the valve below the native annulus. (B) shows a valve position into the aorta (see also
Figure 20). (C) shows a valve positioned within the LVOT. Abbreviation as in Figure 7.
FIGURE 11 Malpositioning of the THV
Positioning of the THV too ventricular (low), with failure to cover the native cusps, risks native leaﬂet overhang. In this simultaneous multiplane
image, the THV leaﬂet has become entrapped by the bulky calcium of the overhanging native cusp (A, yellow arrow) (Online Video 10), resulting in
signiﬁcant aortic regurgitaton (B, yellow arrow) (Online Video 11). Abbreviation as in Figure 8.
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FIGURE 12 Acute Proximal Aortic Dissection
The transcatheter valve (A and C, blue arrows) is well positioned; however, a dissection ﬂap is seen (red arrows) from long axis (A) and short
axis (B) views. The complex nature of the dissection is only appreciated by 3-dimensional imaging (C, multiple red arrows) (Online Video 12).
This complication led to acute tamponade requiring open heart surgery.
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Online Videos 14 and 15). Simultaneous multiplane
imaging allows an accurate assessment of the loca-
tion of the calcium, which has been shown to be a
predictor of PAR secondary to malapposition of the
THV skirt. A risk/beneﬁt analysis should be per-
formed when assessing the possible effectiveness of
re-ballooning to treat PAR because a small leak
adjacent to a rigid calcium nodule may not resolve
by using this intraprocedural therapy. Severe
dystrophic calciﬁcation extending typically from the
left coronary cusp into the LVOT will be forcedFIGURE 13 Delayed Proximal Aortic Dissection
A proximal aortic dissection was diagnosed late (>6months) after TAVR by
imaging. The dissection ﬂap (red arrows) extends to the sinotubular juncti
Abbreviation as in Figure 5.through the annulus/adjacent myocardium during
balloon inﬂation (Figure 15A). The resultant periaortic
hematoma (Figure 15B, Online Video 16) and rapidly
accumulating pericardial effusion (Figure 15C), as well
as the atypical ﬂow originating from the annulus
(Figure 15D, Online Video 17), should immediately
indicate the diagnosis of annular rupture. In addition
to treatment of tamponade with pericardial drainage,
rapid initiation of cardiopulmonary bypass should
be considered.
Periaortic and Intramural Hematoma. Microrupture of
the aorta resulting in periaortic hematoma deservesusing 2-dimensional (A and B) and 3-dimensional (C) (Online Video 13)
on but not into the sinuses, and the patient was treated conservatively.
FIGURE 14 LVOT Calcium and Risk of PAR
Using simultaneous multiplane imaging from the long-axis view (A) (Online Video 14), the level of orthogonal imaging plane (indicated by the
dotted white line) is in the LVOT. LVOT calcium is seen in the short-axis view (yellow arrow) with a wire also across the valve (red arrow). After
TAVR (B) (Online Video 15), a small jet of PAR (yellow arrow) was noted adjacent to the LVOT calcium. The mild central regurgitation (green
arrow) resolved once the wire was removed. PAR ¼ paravalvular aortic regurgitation; other abbreviations as in Figures 5 and 7.
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single-site incidence of 1.6% can be managed medi-
cally if recognized early (34). In contradistinction to
intramural hematoma (which is bleeding into the wall
of the aorta), periaortic hematoma arises from a
microperforation of all 3 layers of the aorta, and the
hematoma that forms appears as a tissue-density
mass around the outside of the aortic root
(Figures 16A and 16B). The perforation likely occurs
after stretching of the aortic wall from displaced
bulky calcium during balloon inﬂation/deployment of
the THV. This process appears to be self-limiting,
with the microperforation sealing quickly once
the balloon is deﬂated or the aorta is no longer
stretched. Conservative management of the periaortic
hematoma (including administration of protamine,continued intubation with restricted activity, and
meticulous blood pressure control) result in excellent
outcomes. Failure to recognize this complication,
however, may result in uncontrolled hypertension,
leading to continued bleeding within the wall of the
aorta and resulting in an intramural hematoma
(Figure 17). Although the outcomes in patients with
TAVR are unknown, intramural hematomas in the
ascending aorta have been associated with mortality
rates as high as 40% when treated medically (74).
Aortic Regurgitation. It is important to distinguish be-
tween post-TAVR PAR and central aortic regurgita-
tion since the approach to treatment of these 2
entities are different.
Paravalvular Aortic Regurgitation. Numerous studies
have shown an association between post-procedural
FIGURE 15 LVOT Calcium and Risk of Annular Rupture
Immediately after TAVR, the severe dystrophic calciﬁcation extending from the left coronary cusp into the LVOT caused annular disruption,
which is easily imaged on 3-dimensional (3D) reconstruction (A, red arrow). Immediately after deployment, a periaortic hematoma (B, yellow
arrows) (Online Video 16) and rapidly accumulating pericardial effusion (C, green asterisk) are seen. Color Doppler showed abnormal ﬂow
originating from the annulus but directed into the center of the LVOT (D, red arrow) (Online Video 17). Abbreviations as in Figures 5 and 7.
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generating intense interest in determining the
factors that predict the occurrence of PAR. A recent
meta-analysis conﬁrms the importance of 3 factors:
undersizing of the annulus, severity of aortic
calciﬁcation, and implantation depth (49).
Determining the severity and etiology of PAR is a
primary focus of post-TAVR imaging. The extent of
calciﬁcation and asymmetric distribution, as well as
the location of calcium on the aortic wall, valve
commissure, or THV landing zone, have all been
implicated as etiologies of PAR (44,47,81–86). The
location and severity of calciﬁcation within the LVOT
should be ascertained before TAVR; if the severity is
less than mild, PAR is usually localized to regions in
which calcium may prevent stent frame apposition
(Figure 14). If there is a signiﬁcant risk of rupture or
the risk of central regurgitation from overexpansion
is high, then no further intervention may be war-
ranted. If the severity of PAR is greater than mild inthe setting of a low-risk “landing zone” (i.e., no bulky
calcium in the LVOT or annulus), intervention with
either a post-dilation or a valve-in-valve procedure
may then be warranted.
Determining the severity of PAR and thus the
appropriate intraprocedural treatment remains chal-
lenging for numerous reasons. First, the ASE
has suggested numerous qualitative and semi-
quantitative parameters for assessing surgical pros-
thetic PAR (87). However, the irregular shape,
atypical direction, and number of paravalvular jets
seen after TAVR makes assessment using these
traditional methods questionable. In addition, 1 of
the semiquantitative parameters mentioned in the
ASE guidelines (i.e., circumferential extent of the
jet) had little validation. Subsequent to this guide-
line, the updated VARC-2 (Valve Academic Re-
search Consortium) consensus document (88), as
well as methods used for the PARTNER trial (89),
used different cutoffs for this parameter: no PAR
FIGURE 17 Intramural Hematoma
Bleeding into the wall of the aorta is seen as thickening of the wall between the adventitia (yellow arrows) and endothelium (green arrows).
In the long axis view (A), this may be associated with periaortic hematoma (red arrows). (B) shows extension into the descending aorta with
a circumferential thickening of the wall.
FIGURE 16 Periaortic Hematoma
A self-limited microperforation of all 3 layers of the aorta may result in a hematoma forming around the outside of the aortic root. (A) shows a
simultaneous multiplane image of the native aortic root, and B (red arrows) shows the self-contained periaortic hematoma which formed after
transcatheter aortic valve replacement, contained by the aortic adventitia. Failure to recognize and appropriately respond to this complication
may result in continued bleeding into the adventitial space and aortic rupture.
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FIGURE 18 Grading of PAR by Circumferential Extent of the Jet From Short Axis Views
Assessment of the circumferential extent of PAR should be performed just below the THV
stent (within the LVOT). No PAR (no regurgitant color ﬂow) is deﬁned as a trace (pinpoint
jet in aortic valve short axis view). (A) (Online Video 18) shows mild PAR (jet arc lengths are
discontinuous, but total <10% of the aortic valve [AV] annulus short axis view circum-
ference). (B) (Online Video 19) shows moderate PAR (jet arc lengths are discontinuous, but
total 10% to 30% of the AV annulus short axis view circumference). (C) (Online Video 20)
shows severe PAR (jet arc lengths are discontinuous, but total >30% of the AV annulus
short axis view circumference). Abbreviations as in Figures 7, 8, and 14.
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303(no regurgitant color ﬂow), a trace (pinpoint jet in
AV short axis view), mild (jet arc length is <10% of
the AV annulus short axis view circumference),
moderate (jet arc length is 10% to 30% of the AV
annulus short axis view circumference), and severe
(jet arc length is >30% of the AV annulus short
axis view circumference) (Figure 18, Online Videos 18,
19 and 20). It is important to note that frequently the
jets are multiple and discontinuous. The circumfer-
ential extent should be measured as the sum of the
separate jets, not the paravalvular arc which includes
the nonregurgitant space between jets.
Recent studies using cardiac magnetic resonance
(CMR) conﬁrm the limitations of echocardiographic
methods. Cawley et al. (90) reported higher interob-
server variability of aortic regurgitation quantiﬁca-
tion by TTE (r ¼ 0.89) compared with CMR (r ¼ 0.99).
Abdel-Wahab et al. (91) also compared echocardio-
graphic assessment of PAR with CMR in a subset of
patients randomized to receive balloon-expandable
and self-expanding valves in the CHOICE (Trans-
catheter Heart Valves in High Risk Patients With
Severe Aortic Stenosis: Medtronic CoreValve vs
Edwards SAPIEN XT) trial. The study found that
echocardiography underestimated PAR severity after
TAVR only for the CoreValve device. Most recently,
Ribeiro et al. (92) systematically looked at the semi-
quantitative, multiparametric approach advocated by
the ASE as well as the VARC-2 suggestion of circum-
ferential extent of the PAR jets. The authors found
that the multiparametric approach underestimated
aortic regurgitation severity using CMR by 1 grade in
59.5% and by 2 grades in 2.4%. Circumferential extent
of prosthetic PAR overestimated severity in 38%,
exhibiting a poor correlation with CMR regurgitant
volume and fraction (r2 ¼ 0.32, p ¼ 0.084; r2 ¼ 0.36,
p ¼ 0.054, respectively).
Although quantitation of PAR by using echocardi-
ography is advocated by all guidelines, the current
method is limited by the number of technically difﬁ-
cult measurements, which restricts the applicability
of these techniques for intraprocedural use. Quanti-
tation of prosthetic regurgitant volume, effective
regurgitant oriﬁce area, and regurgitant fraction
should be performed by using ASE methods (87,93).
The regurgitant volume should be calculated as the
difference between the stroke volume across any
nonregurgitant oriﬁce (right ventricular outﬂow tract
or mitral valve) and the stroke volume across the
LVOT. Interobserver variability of this calculation is
reasonable, although higher than for CMR (90).
3D echocardiography may overcome the limita-
tions of current 2-dimensional (2D) techniques.
A recent study compared the 5 VARC-2 2D TTE
FIGURE 19 3D Color Doppler Quantitation of PAR
(A) Simultaneous multiplane 2-dimensional imaging of PAR (yellow arrows), which by circumferential extent suggests moderate to severe
PAR (Online Video 21). (B) Multiplanar reconstruction of the 3-dimensional (3D) color Doppler jet. (C) The 3D planimetry of the narrow,
irregularly shaped jet, which measures 6 mm2 at the vena contracta consistent with mild PAR. Abbreviation as in Figure 14.
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TTE-quantiﬁed regurgitant volume and fraction, as
well as CMR TAVR (94). The narrowest conﬁdence
intervals for regurgitant volume and regurgitant
fraction were between CMR and 3D TEE; there was no
signiﬁcant difference between these 2 modalities in
the moderate and severe grades. Figure 19 (Online
Video 21) presents an example of intraprocedural
quantiﬁcation of PAR by using 3D color Doppler.
Central Aortic Regurgitation. Signiﬁcant central aortic
regurgitation following TAVR may require place-
ment of a second THV or valve-in-valve procedure
(Figure 20). In a recent study of acute valve-in-valve
placement (38), severe central THV regurgitation
was due to leaﬂet malfunction in 54% of cases, mal-
positioning in 41% of cases, and unknown causes in
5% of cases. Transcatheter leaﬂet malfunction may
occur in a number of situations. Calcium may pro-
trude through the stented valve, impinging leaﬂet
motion. A low-lying THV may leave native leaﬂet
overhanging the THV stent, which can entrap the
THV leaﬂets (Figure 11). Post-dilation may causeeversion of the THV leaﬂet (although this does not
occur with newer iterations of the balloon-expand-
able valve). Finally, a tilted/canted valve may distort
the THV frame and result in severe central aortic
regurgitation (Figures 20A and 20B). This complica-
tion can be treated successfully with a valve-in-valve
procedure (Figure 20C). Transcatheter leaﬂets may
become pinned open by the stiff wire (Figure 21,
Online Video 22); this complication frequently re-
solves with removal of the wire. In the setting
of leaﬂet eversion and before a valve-in-valve pro-
cedure, placement of a pigtail catheter in each of the
sinuses of the TAVR valve may help in ameliorating
the central insufﬁciency by causing the everted
leaﬂet to close normally. Again, with later iterations
of the balloon-expandable valve, the leaﬂet design
prevents this eversion from occurring. Although
rarely performed (2.4% of cases in the PARTNER 1
trial), the majority (88.5%) of repeat valves were
performed immediately. When valve-in-valve is per-
formed in the setting of PAR, the etiology was most
commonly malpositioning.
FIGURE 20 Malposition of the THV and Central Aortic Regurgitation
Severe tilting/canting of the transcatheter valve (yellow arrows) occurred in the setting of
operator-independent motion of the valve during balloon inﬂation (A). This malpositioning
prevents normal closure of the valve, resulting in severe central aortic regurgitation (B, red
arrows). After placement of a second transcatheter valve (valve-in-valve salvage), there
was no central regurgitation but moderate paravalvular regurgitation was seen (C, blue
arrows). Abbreviation as in Figure 8.
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from any of the wires or catheters that enter the
cavity. Right ventricular perforation from the pacing
wire may go undetected until removal of the wire. In
Figure 22 (Online Videos 23 and 24), rapid but focal
accumulation of pericardial blood was seen on intra-
procedural imaging only after removal of the pacing
wire, emphasizing the need for continuous imaging
throughout the procedure. Perforation of the left
ventricle is typically seen immediately, with accu-
mulation of relatively echodense pericardial blood,
associated with tamponade physiology (compression
of the ventricular or atrial chambers) and hemody-
namic collapse. Figure 23A shows an initially unde-
tected left ventricular (LV) perforation in the setting
of a transaortic TAVR. This patient was stable for
weeks before presenting with progressive dyspnea
and a large pseudoaneurysm. Figure 23B shows a LV
perforation that occurred in the setting of cardiopul-
monary resuscitation after a long pacing run before
BAV; perforation likely occurred secondary to the
BAV catheter being pushed through the left ventricle
during chest compressions. Both TAVR migration and
compression have been reported after cardiopulmo-
nary resuscitation. Figure 24 shows an example of the
initial circular shape of the THV (Figures 24A and 24B)
in a patient with acute rupture requiring chest com-
pressions. Subsequent images reveal a ﬂattening THV
(Figures 24C [Online Video 25] and 24D [Online Video
26]), and color Doppler suggested turbulent trans-
aortic ﬂow.
Perforation of the cardiac tissue at the proximal or
distal border of the THV can lead to unusual intra-
cardiac communications. These perforations are
likely related to signiﬁcant calciﬁc protrusions near
the edge of the stent. The most common intracardiac
shunt is a ventricular septal defect which occurs at
the proximal edge of the THV; the offending calcium
extends into the LVOT from the right coronary cusp or
commissure between the right coronary cusp and the
noncoronary cusp (Figure 25, Online Videos 27 and 28)
(95–98). Because rupture of the septum in this region
will likely also result in malapposition of the edge of
the THV, PAR may accompany this complication.
Spectral Doppler ﬂow proﬁles for this unusual ven-
tricular septal defect may thus have prominent dia-
stolic ﬂow, as well as typical systolic ﬂow (Figure 26).
The diastolic ﬂow is a result of PAR; ﬂow from
the aorta crosses the ventricular septal defect. The
systolic ﬂow is a result of the typical ventricular
left-to-right ﬂow. Intraprocedural treatment of this
complication is limited given the proximity to the
new THV; however, transcatheter paravalvular leak
closure may reduce the diastolic ﬂow.Rare cases of muscular ventricular septal de-
fects have also been reported after transapical im-
plantation of the THV (99,100). This complication is
due to direct perforation by the apical cannula and
can be avoided with imaging of the cannulation site
before apical puncture. Using TEE imaging, the sur-
geon can determine the optimal position of cannula-
tion, avoiding the right ventricle and interventricular
FIGURE 21 Severe Central Aortic Regurgitation
In these color compare images a transcatheter valve leaﬂet has been pinned open (A, yellow arrows) (Online Video 22) resulting in severe
central aortic regurgitation (A and B, red arrows). This may be due to the stiff wire (B, green arrows), which can respond to removal or
manipulation of the wire.
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(see Complications unique to transapical TAVR in
subsequent text).
Coronary occlusion. Coronary obstruction is related to
the displacement of a calciﬁed native AV leaﬂet into
the coronary ostium. A recent meta-analysis (41) re-
ported a <1% incidence of coronary occlusion (range
0.0% to 4.1%). Most of the reported 24 cases pre-
sented with persistent severe hypotension (87.5%),
although ST-segment changes and ventricular ar-
rhythmias also occurred. The majority of occlusions
occurred immediately after valve implantation
(83.3%) due to displacement of the calciﬁed native
cusp over the coronary ostium. Rarely patientspresented within the ﬁrst few hours after the proce-
dure (8.3%), or within the ﬁrst 2 days after the
procedure (8.3%). Coronary obstruction occurred
more frequently in the left coronary artery (LCA)
(83.3%) and was successfully treated with percuta-
neous coronary intervention in 91.3% of cases. Risk
factors appeared to be female sex and no previous
bypass surgery. The height of the left main above the
annulus was on average 10.3 mm (range 7 to >12 mm),
and w60% of occlusions occurred with a coronary
height >10 mm. A narrow aortic root with shallow
sinuses of Valsalva (leaving little room to accommo-
date the calciﬁed native aortic leaﬂets after valve
deployment) may also be an important factor.
FIGURE 22 Acute Right Ventricular Perforation
After successful TAVR with no evidence of conduction abnormalities, the pacing wire was removed with immediate accumulation of blood seen
by simultaneous multiplane imaging within the pericardial space (A) (Online Video 23) adjacent to the right ventricle (*). This resulted in
obstruction to the tricuspid valve ﬂow (B) (Online Video 24) and ensuing tamponade physiology. Abbreviation as in Figure 5.
FIGURE 23 Ventricular Perforation
(A) A small, undetected left ventricular perforation occurred in the setting of a transaortic TAVR. On follow-up imaging, a ventricular pseu-
doaneurysm was seen (A) with ﬂow from the left ventricle (yellow arrow) to the pericardial space (green asterisk). (B) An example of a BAV
catheter (blue arrow) through the left ventricle at open repair. This complication occurred during cardiopulmonary resuscitation with chest
compressions. Abbreviations as in Figures 2 and 5.
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FIGURE 24 Crushed THV After CPR
(A) The short axis view, and (B) the long axis view after initial deployment of the THV. Chest compressions were subsequently necessary in the
setting of an aortic rupture and short-axis (C) (Online Video 25) and long-axis (D) (Online Video 26) views show narrowing of the anterior-
posterior dimension of the THV. Abbreviation as in Figure 8.
FIGURE 25 Ventricular Septal Rupture
Ectopic calciﬁcation may extend into the LVOT along the membranous septum (A, yellow arrow). After TAVR, deep gastric long axis views may
be the best views for imaging the defect in the membranous septum (B, blue arrow) (Online Video 27) with color Doppler (C) (Online Video 28)
showing systolic ﬂow across a traumatic ventricular septal defect. Abbreviations as in Figures 5 and 7.
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FIGURE 26 Atypical Doppler of Ventricular Septal Rupture From TAVR
(A) A typical continuous wave Doppler across a ventricular septal defect after TAVR. On follow-up transthoracic continuous wave Doppler (B),
there is prominent phasic but pan-cyclic ﬂow representing aortic–to–right ventricular systolic and diastolic shunt. Abbreviation as in Figure 5.
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309Left Main Occlusion. Characterizing “at-risk” anatomy
is of paramount importance in avoiding the compli-
cation of left main occlusion. Because the LCA lies in
the coronal plane, routine 2D echocardiography im-
aging cannot typically allow measurement of LCA
height above the annulus or left coronary cusp length.FIGURE 27 Coronary Occlusion
LM coronary occlusion can be imaged immediately after TAVR (yellow a
hemodynamic collapse (Online Video 29). Abbreviations as in Figures 4One method for predicting left main coronary occlu-
sion is to image the coronary artery during the BAV
procedure (as discussed earlier) (Figure 5). If the LCA
or right coronary artery ostia become occluded by the
bulky calcium of the associated coronary cusp during
BAV, pre-emptive measures should be consideredrrow) and is accompanied by acute left ventricular dysfunction and
and 5.
FIGURE 28 Acute Mitral Valve Regurgitation
At baseline, mitral chordae appear intact (A) (Online Video 30) with trace mitral regurgitation (B). After stiff wire insertion and balloon aortic
valvuloplasty, a ruptured mitral ruptured chordae (C, yellow arrow) (Online Video 31) results in moderate mitral regurgitation (D).
FIGURE 29 SAM of the Mitral Leaﬂet After TAVR
(A) A hypertrophied basal septum but without systolic anterior motion (yellow arrow) and no signiﬁcant mitral regurgitation (B) (Online Video 32)
before TAVR. After valve implantation, there is prominent systolic anterior motion (SAM) (C, blue arrow)with turbulent LVOT ﬂow (D, blue arrow)
(Online Video 33) and mitral regurgitation (*). Abbreviations as in Figures 4 and 7.
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FIGURE 30 Papillary Muscle Transection Secondary to Transapical Cannulation
(A) The transapical cannula in a slightly posterior position (Online Video 34), with associated new-onset severe mitral regurgitation (B). Deep
gastric short axis (C) (Online Video 35) and long-axis (D) views of the left ventricle (LV) conﬁrm that the cannula has passed through the
posteromedial papillary muscle head (yellow arrows).
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311which enable rapid treatment of an occluded coro-
nary following TAVR. These measures may include
positioning a wire or crimped stent in the LCA. Im-
mediate post-TAVR imaging of coronary occlusion by
using 2D echocardiography and color Doppler
(Figure 27, Online Video 29) with associated regional
wall motion abnormalities may prompt conﬁrmation
with coronary angiography.
The etiologies of delayed coronary occlusion are
theoretical. Late embolization of calcium or low ﬂow
with thrombus formation seem plausible. One author
postulated that after TAVR, a periaortic hematoma
may have formed and resulted in right coronary ar-
tery occlusion (101).
Mitral valve regurgitation (acute). MV Apparatus
Compromise (Perforation and Chordal Rupture). A
recent study of Cohort A of the PARTNER I trial showed
that among 30-day survivors who had TAVR,moderate
to severe mitral regurgitation had improved in 57.7%,
was unchanged in 36.5%, and worsened in 5.8% (102).
Although the cause of worsening mitral regurgitationcould not be delineated in that study, both ruptured
chordae resulting in ﬂail leaﬂets, and mitral leaﬂet
perforation have been reported. The latter may be
predicted by a careful assessment of dystrophic
calciﬁcation on the anterior mitral leaﬂet and
avoidance of a low implantation. Acute but reversible
changes in mitral regurgitation may also occur,
mainly under 2 circumstances: primary alteration in
mitral morphology from wire entanglement (Figure 1)
or ruptured chordae (Figure 28, Online Videos 30 and
31) and secondary changes in annular morphology
due to severe ventricular dysfunction (i.e., diffuse
ischemia after long pacing runs) or dilation (i.e.,
acute severe aortic regurgitation).
Signiﬁcant LVOT gradients may occur in up to 14%
of patients after surgical AV replacement (103–107),
with a similar hemodynamic disturbance having been
reported after TAVR (108) (Figure 29, Online Videos 32
and 33). The mechanism is thought to be related to a
small, hypertrophied ventricle and the development
of systolic anterior motion of the mitral leaﬂet.
FIGURE 31 Conﬁrmation of Apical Cannulation Site
After limited thoracotomy, the surgeon indicates the intended site of cannulation with an apical poke, which is easily identiﬁed in 2 orthogonal
views with simultaneous multiplane imaging (A [Online Video 36]). When appropriately identiﬁed, wires pass freely into the LV and across the
AV (B [Online Video 37]). Abbreviation as in Figures 18 and 30.
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312Associated with this ﬁnding is signiﬁcant mitral
regurgitation. Patients at risk for this ﬁnding include
those with a small, hypertrophied ventricle, the use
of catecholamines, narrowing of the LVOT, reduced
circulating blood volume, and septal hypertrophy.
Because of the association with hypotension and
increased mortality (105,106), it is important to
recognize this entity and avoid inotropes or afterload
reduction.
Complications unique to transapical TAVR. Transapical
aortic valve implantation of the balloon-expandable
THV is performed through a mini left anterior thora-
cotomy (47,109,110). Fluoroscopic and TEE guidance
are recommended to locate the optimal cannulation
site as well as guide the procedure. A recent meta-
analysis of transapical TAVR studies revealed the
following incidence of major adverse events: 30-day
mortality (4.7% to 20.8%), cerebrovascular accident
(0.0% to 16.3%), major tachyarrhythmia (0.0% to
48.8%), bradyarrhythmia requiring permanent pace-
maker insertion (0.0% to 18.7%), cardiac tamponade
(0% to 11%), major bleeding (1% to 17%), myocardialinfarction (0% to 6%), aortic dissection/rupture (0%
to 5%), moderate to severe paravalvular leak (0.7% to
24.0%), cardiopulmonary bypass support (0% to 15%);
conversion to surgery (0.0% to 9.5%), and valve-in-
valve implantation (0.6% to 8.0%) (111). Numerous
studies suggest that the learning curve in this proce-
dure may play a signiﬁcant role in outcomes
(47,112,113).
There are a number of complications that are
unique to the transapical approach. Malpositioning of
the apical cannulation site risks perforation of the
right ventricle, ventricular septum, or papillary
muscle (Figure 30, Online Videos 34 and 35). These
complications can be avoided by using intra-
procedural imaging. Figure 31 shows an example of
the surgeon conﬁrming the intended cannulation
site. After a limited thoracotomy, the surgeon in-
dicates the site with an apical poke, which is easily
identiﬁed in 2 orthogonal views with simultaneous
multiplane imaging (Figure 31A, Online Video 36).
When appropriately identiﬁed, wires pass freely into
the left ventricle and across the AV (Figure 31B, Online
Video 37).
FIGURE 32 Indirect Obstruction of Distal Coronary Flow After Cannula Removal and Apical Closure Due to Tension From the
Purse-String Sutures
Marked apical hypokinesis involving more than the immediate cannulation site is shown in this diastolic (A) and systolic (B) (Online Video 38)
multiplane (Online Video 38, short-axis and long-axis) deep gastric views of the LV. Abbreviation as in Figure 30.
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313Acute myocardial infarction may occur by either
direct or indirect compromise of distal coronary ﬂow.
The location of the apical cannulation site is in part
dictated by the location of the left anterior descending
aorta or associated coronary artery bypass grafts.
Perforation of the vessel is thus unlikely given the
ability to directly visualize the vessel. However, indi-
rect obstruction of distal coronary ﬂow after cannula
removal and apical closure can occur due to tension
from the purse-string sutures (114). This rare compli-
cation can be ﬁrst detected by intraprocedural TEE,
which shows marked apical hypokinesis involving
more than the immediate cannulation site (Figure 32,
Online Video 38). Treatment by implanting a coronary
stent may be warranted.
Because of the direct cannulation through the
ventricular apex, acute laceration and hemorrhage
are possible. Direct visualization of the apex during
closure should reduce the likelihood of this compli-
cation; nonetheless, persistent bleeding and peri-
cardial tamponade may occur. Development of a
pseudoaneurysm may result from incomplete closure
of the apical cannulation site but may not be detected
until well after the procedure (Figure 33, Online
Videos 39 and 40).Malpositioning of the transcatheter valve. Although
operator-independent motion of the balloon-
expandable valve is usually predictable and has been
well described for the ﬁrst generation and second
generation balloon-expandable valves (67), there is
rarely an unexpected extreme motion of the valve.
Embolization of the valve into the aorta may itself
result in aortic trauma, but if not, intentional reposi-
tioning of the valve into the descending aorta beyond
the great arteries (Figure 34) may be necessary before
attempted deployment of a second valve at the aortic
annulus. Translocation of the valve into the ventricle
can also occur when the initial position of the valve is
too low (Figure 35, Online Videos 41 and 42). This
complication typically requires open retrieval of the
transcatheter valve.
CONCLUSIONS
This imaging compendium from the PARTNER trials is
a compilation of intraprocedural complications of
balloon-expandable THV implantation imaged by us-
ing intraprocedural TEE. Although newer iterations of
the balloon-expandable valve, as well as other valve
designs, may signiﬁcantly reduce the rate of some
FIGURE 33 Apical Pseudoaneurysm Formation After Transapical Cannulation
This patient complained of an expanding chest wall mass (A, red asterisk) 6 months after transapical TAVR (yellow arrows show the mini-
thoracotomy scar). Transthoracic imaging revealed a pseudoaneurysm, best seen from the apical views (C, red asterisk) (Online Video 39) with
systolic ﬂow detected on color Doppler (D, blue arrow) (Online Video 40). The ﬁnding was conﬁrmed by both echocardiographic intravenous
contrast study as well as chest computed tomography (CT) (B). Abbreviation as in Figure 5.
FIGURE 34 Distal Migration of the THV
Migration of the THV into the aortic arch (A, red arrow)may occur with high positioning of the THV. In this patient, with placement of a covered
stent (B, yellow dashed arrows) was performed to exclude the valve component of the THV. Abbreviation as in Figure 8.
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FIGURE 35 Translocation of the THV into the Ventricle
Migration of the THV into the LV can occur when the initial position of the valve is too low. The simultaneous multiplane image (A) (Online
Video 41), with the long-axis view of the transcatheter valve on the left and the short-axis view on the right, shows the low position of the
transcatheter valve (blue arrows) with signiﬁcant native leaﬂet overhang (red arrows). Translocation of the transcatheter valve is seen by
both 2-dimensional (B) and 3-dimensional (C) (Online Video 42) imaging. Abbreviations as in Figures 8 and 30.
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315complications such as PAR, recognizing, predicting, or
effectively reacting to all complications remains an
important aspect of improving the safety of TAVR. As
the ﬁeld progresses and lower risk patients are treated,
early recognition of complications will remain an
important advantage of intraprocedural imaging.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
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